This study investigated the health-functional properties of a lactic fermented pomegranate juice (FPJ) enriched with pomegranate seed oil (FPJO) by using the fruit-origin strain Lactiplantibacillus paraplantarum CRL 2051 (FPJO-CRL2051). For this aim, the in vitro human antiplatelet aggregation effect and antioxidant activities were determined in the fermented juices while in vivo studies using high-fat-diet (HFD) C57BL/6 mice fed with a high-fat diet or pomegranate fermented juices for 8 weeks were performed. A high anti-platelet aggregation activity for FPJO-CRL2051 was determined. The formulated juice was administered to C57BL/6 HFD mice over 8 weeks, which showed a significant decrease in triglycerides, LDL-C, and pro-inflammatory cytokines levels. The FPJO-CRL2051 administration was effective in ameliorating liver damage caused by HFD, reducing fat accumulation and oxidative biomarkers, and improving the liver fatty acid profile by incorporation of conjugated fatty acids. This study shows the significance of lactic fermentation in developing novel fermented plant-based beverages with enhanced functional activities with a circular economy approach for the prevention of metabolic disorders.

This study investigated the ability of Lactiplantibacillus paraplantarum CRL2051 and Lactiplantibacillus plantarum CRL2030, two lactic acid bacteria isolated from fruits, to ferment pomegranate juice to produce beverages with extended shelf life and functional properties. Lactic acid bacteria consumed glucose and fructose as carbon sources, producing mainly lactic acid. Both strains were initially grown in juice at 30 degrees C for 48 h, then refrig-erated at 4 degrees C for 28 days. During fermentation and cold storage, the total phenolic content and antioxidant capacity were conserved in fermented pomegranate juices. The functionality studies of the fermented beverages administered to C57BL/6 mice fed a high-fat diet were evaluated over 6 weeks. Pomegranate juice supple-mentation led to a marked improvement in glucose and triglycerides serum profile, which decreased around 40% and up to 48%, respectively, and counteracted fat deposition and body weight gain. The high-fat diet treatment significantly incremented the aspartate aminotransferase activity in the liver, whereas fermented pomegranate juice consumption slightly reduced it. Liver histological changes associated with a high-fat diet were significantly reverted in juice-treated animals. Our findings evidenced the biological benefits of a novel functional beverage obtained by lactic fermentation of pomegranate juice; this functional drink may protect against weight gain, liver damage, and dyslipidemia induced by a high-fat diet consumption.

The biochemical and functional properties of fermented Annona cherimola Mill. (cherimoya) juice using five lactic acid bacteria (LAB) isolated from autochthonous fruits from Northwestern Argentina were studied in this work. Fermentation was carried out at 30 degrees C for 48 h followed by a 21 day-storage period at 4 degrees C. The assayed LAB grew well during fermentation (final count of 10(8) CFU/mL, Delta pH ca. 1 U) and survived after the storage period. All strains consumed fructose and glucose present in cherimoya juice as energy sources, with the consequent synthesis of lactic and/or acetic acids as final metabolic products. However, only two of the five evaluated strains were capable to produce fermented cherimoya juices with a perceptible color change. Due to lactic acid fermentation, a moderate reduction in the total phenolic content (between 13% and 43%) was observed in the majority of the samples, although no change in the antioxidant capacity was detected. The fermented cherimoya juices showed a weak antiplatelet activity when adenosine diphosphate agonist was used. The findings of this study evidenced the potential use of Annona cherimola Mill. fermented juice as a novel matrix for the formulation of stable functional beverages with appealing nutritional and functional properties.